Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Immunization of mice by Hollow Mesoporous Silica Nanoparticles as carriers of Porcine Circovirus Type 2 ORF2 Protein
oleh: Guo Hui-Chen, Feng Xiao-Ming, Sun Shi-Qi, Wei Yan-Quan, Sun De-Hui, Liu Xiang-Tao, Liu Zai-Xin, Luo Jian-Xiong, Yin Hong
Format: | Article |
---|---|
Diterbitkan: | BMC 2012-06-01 |
Deskripsi
<p>Abstract</p> <p>Backgroud</p> <p>Porcine circovirus type 2 (PCV2) is a primary etiological agent of post-weaning multi-systemic wasting syndrome (PMWS), which is a disease of increasing importance to the pig industry worldwide. Hollow mesoporous silica nanoparticles (HMSNs) have gained increasing interest for use in vaccines.</p> <p>Methods</p> <p>To study the potential of HMSNs for use as a protein delivery system or vaccine carriers. HMSNs were synthesized by a sol–gel/emulsion(oil-in-water/ethanol) method, purified PCV2 GST-ORF2-E protein was loaded into HMSNs, and the resulting HMSN/protein mixture was injected into mice. The uptake and release profiles of protein by HMSNs <it>in vitro</it> were investigated. PCV2 GST-ORF2-E specific antibodies and secretion of IFN-γ were detected by enzyme-linked immunosorbent assays, spleen lymphocyte proliferation was measured by the MTS method, and the percentage of CD4+ and CD8+ were determined by flow cytometry.</p> <p>Results</p> <p>HMSNs were found to yield better binding capacities and delivery profiles of proteins; the specific immune response induced by PCV2 GST-ORF2-E was maintained for a relatively long period of time after immunization with the HMSN/protein complex.</p> <p>Conclusion</p> <p>The findings suggest that HMSNs are good protein carriers and have high potential for use in future applications in therapeutic drug delivery.</p>